Biotage Makes a Change in Top Management after Business Area President resigns
David Patteson has been with Biotage for seven years during which time he has very successfully built up the Global operations. In the last years he also led the integration of the acquired companies and the cost reductions that followed. Today, Biotage is the world leading supplier in instruments, reagents and services for the Medicinal Chemists.
The forthcoming CEO of Biotage, Torben Jörgensen, will take over Mr Pattesons responsibilities with immediate effect and work alongside him until 1 April.
Discovery Chemistry, which represents about 85 percent of Biotages annual turnover, supplies products and services for three prominent market segments, Medicinal Chemistry, Analytical Chemistry and Process Development. Primary products include microwave synthesis, resins and solid phase extraction (SPE), flash purification cartridges and systems, and reaction screening instruments, which target chemists in research organizations worldwide.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.